Comparison of HCV prevalence in Pakistan and Iran; An insight into future

Hepatitis Monthly

Volumn 14, Issue 1, 2014, Pages

  Afzal, Muhammad Sohail ^a   Ahmed, Tahir ^a   Zaidi, Najam us Sahar Sadaf ^a  

^a NATIONAL UNIVERSITY OF SCIENCES AND TECHNOLOGY   (Pakistan)

Author keywords

Awareness; Health promotion; Hepatitis C; Infection; Prevalence

Indexed keywords

AWARENESS; GENETIC VARIABILITY; HEALTH PROMOTION; HEPATITIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOMODULATION; IRAN; LETTER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; PAKISTAN; PREVALENCE;

EID: 84892617453     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.11466     Document Type: Letter

References (8)

1. Shakeri MT, Nomani H, Ghayour Mobarhan M, Sima HR, Gerayli S, Shahbazi S, et al. The prevalence of hepatitis C virusin mashhad, iran: a population-based study. Hepat Mon. 2013;13(3): e7723.
2. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol. 2002;17(10):1092-7.
3. Anjum S, Ali S, Ahmad T, Afzal MS, Waheed Y, Shafi T, et al. Sequence and structural analysis of 3' untranslated region of hepatitis C virus, genotype 3a, from pakistani isolates. Hepat Mon. 2013;13(5): e8390.
4. Safi SZ, Afzal MS, Waheed Y, Butt UJ, Fatima K, Pervez Y, et al. Seroprevalence of hepatitis C and human immunodeficiency viruses in blood donors of northwestern Pakistan. Asian Biomed. 2011;5(3):389.
5. Waheed Y, Saeed U, Anjum S, Afzal MS, Ashraf M. Development of Global Consensus Sequence and Analysis of Highly Conserved Domains of the HCV NS5B Prote in. Hepat Mon. 2012;12(9): e6142.
6. Alavian SM. Triangular clinics: The way of the future. Hepat Mon. 2005;5(3):51-2.
7. Afzal MS, Tahir S, Salman A, Baig TA, Shafi T, Zaidi NU, et al. Analysis of interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan. J Infect Dev Ctries. 2011;5(6):473-9.
8. Afzal MS, Anjum S, Zaidi NU. Effect of Functional Interleukin-10 Polymorphism on Pegylated Interferon-alpha Plus Ribavirin Therapy Response in Chronic Hepatitis C Virus Patients Infected With 3a Genotype in Pakistani Population. Hepat Mon. 2013;13(6): e10274.